UTI-lizer develops diagnostic tests for urinary tract infections.
UTI-lizer has raised $653K in total funding. The most recent round was Seed. The last funding was announced in May 2023.
UTI-lizer's investors include Almi Invest, Sting, Propel Capital.
UTI-lizer is headquartered in Stockholm, Sweden.
UTI-lizer develops diagnostic tests for urinary tract infections.
UTI-lizer is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"UTI-lizer — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/uti-lizer. Accessed July 19, 2026.
VCBacked. (2023). UTI-lizer — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/uti-lizer
{{cite web |title=UTI-lizer — Funding & Investors |url=https://www.vcbacked.co/company/uti-lizer |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated